Maci 3CM x 5CM implant sheets
Ended Awarded Last action
- Contract number
- SPE2DR26FHKV2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,660
Award facts
- Contract value 100% obligated
- $72,659.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $72,659.87 for MACI 3CM x 5CM implant sheets on January 8, 2026, with completion expected by January 30, 2026. This firm fixed-price delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award represents a single delivery order issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.9 billion ceiling value and extends through December 31, 2036.
DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities. MACI (matrix-assisted chondrocyte implantation) implant sheets are specialty surgical products used in orthopedic and cartilage repair procedures within military medical systems. The contractor's registration in the System for Award Management dates to July 18, 2001, and the company has demonstrated substantial federal contracting performance across multiple therapeutic categories and product lines, positioning it as a critical supplier within the federal military pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FHKV2?
SPE2DR26FHKV2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FHKV2 worth?
The government has obligated $72,660 on SPE2DR26FHKV2.
Is contract SPE2DR26FHKV2 an order under another contract?
Yes. SPE2DR26FHKV2 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKV2 competed?
The extent of competition for SPE2DR26FHKV2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award